Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial cells through activating peroxisome proliferator activator receptor‐alpha signalling
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.17963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Tzong-Bor Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hyperbaric Oxygen Medicine, Chi Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Retinal Pigment Epithelium, PPAR alpha, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chi Mei Medical Center.
Abstract (Originalsprache)
Retinal ischemia followed by reperfusion (IR) is a common cause of many ocular disorders, such as age‐related macular degeneration (AMD), which leads to blindness in the elderly population, and proper therapies remain unavailable. Retinal pigment epithelial (RPE) cell death is a hallmark of AMD. Hyperbaric oxygen (HBO) therapy can improve IR tissue survival by inducing ischemic preconditioning responses. We conducted an in vitro study to examine the effects of HBO preconditioning on oxygen–glucose deprivation (OGD)‐induced IR‐injured RPE cells. RPE cells were treated with HBO (100% O 2 at 3 atmospheres absolute for 90 min) once a day for three consecutive days before retinal IR onset. Compared with normal cells, the IR‐injured RPE cells had lower cell viability, lower peroxisome proliferator activator receptor‐alpha (PPAR‐α) expression, more severe oxidation status, higher blood‐retinal barrier disruption and more elevated apoptosis and autophagy rates. HBO preconditioning increased PPAR‐α expression, improved cell viability, decreased oxidative stress, blood‐retinal barrier disruption and cellular apoptosis and autophagy. A specific PPAR‐α antagonist, GW6471, antagonized all the protective effects of HBO preconditioning in IR‐injured RPE cells. Combining these observations, HBO therapy can reverse OGD‐induced RPE cell injury by activating PPAR‐α signalling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hyperbaric Oxygen Medicine, Chi Mei Medical Center, Tainan, Taiwan.
- Division of Plastic Surgery, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Biotechnology and Food Technology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
- Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
- Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.
- Division of Neurosurgery, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan.
ORCID-Profile: Tzong-Bor Sun, Ching-Ping Chang
Förderung
- Chi Mei Medical Center
Zitieren
APA
Sun, T. B., Huang, K. F., Niu, K. C., Lin, C. H., Liu, W. P., Yeh, C. H., Kuo, S. C., & Chang, C. P. (2023). Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial cells through activating peroxisome proliferator activator receptor‐alpha signalling. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17963
Vancouver
Sun TB, Huang KF, Niu KC, Lin CH, Liu WP, Yeh CH, et al. Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial cells through activating peroxisome proliferator activator receptor‐alpha signalling. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17963
BibTeX
@article{Sun2023,
author = {Sun, Tzong-Bor and Huang, Kuo-Feng and Niu, Ko-Chi and Lin, Cheng-Hsien and Liu, Wen-Pin and Yeh, Chao-Hung and Kuo, Shu-Chun and Chang, Ching-Ping},
title = {Hyperbaric oxygen therapy suppresses hypoxia and reoxygenation injury to retinal pigment epithelial cells through activating peroxisome proliferator activator receptor‐alpha signalling},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.17963}
}
EUVIMED